1. [LB.01.13] THE USE OF CARDIOVASCULAR PREVENTIVE DRUGS IN SUBJECTS AFTER MYOCARDIAL INFARCTION. A POPULATION BASED STUDY. (September 2017) Authors: Redon, J.; Sanchis, J.; Uso, R.; Trillo, J.L.; Fernandez, A.; Morales, F.; Orozco, D.; Gil, V. Journal: Journal of hypertension Issue: Volume 35(2017)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. [LB.03.12] THE USE OF CARDIOVASCULAR PREVENTION DRUGS IN SUBJECTS AFTER STROKE OR TIA. A POPULATION STUDY. (September 2017) Authors: Redon, J.; Uso, R.; Trillo, J.L.; Fernandez, A.; Morales, F.; Orozco, D.; Gil, V.; Sanchis, J. Journal: Journal of hypertension Issue: Volume 35(2017)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. IMPACT OF CARDIOVASCULAR DRUG ON ALL-CAUSE MORTALITY IN SECONDARY PREVENTION. A POPULATION STUDY. (June 2018) Authors: Redon, J.; Uso, R.; Trillo, J.L.; Fernandez, A.; Morales, F.; Orozco, D.; Gil, V.; Sanchis, J. Journal: Journal of hypertension Issue: Volume 36(2018)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗